Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: ARTRITE REUMATOIDE, ADJUVANTES IMUNOLÓGICOS
ABNT
TAKASHIRO, Fernanda Leika e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 29 jun. 2024. , 2015APA
Takashiro, F. L., Ribeiro, A. G., & Kano, E. K. (2015). Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Takashiro FL, Ribeiro AG, Kano EK. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 39 res. FCF073.[citado 2024 jun. 29 ]Vancouver
Takashiro FL, Ribeiro AG, Kano EK. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 39 res. FCF073.[citado 2024 jun. 29 ]